U.S. Markets open in 27 hrs, 30 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,464.40 | 30.69 | 0.29% |
| NASDAQ | 2,176.05 | 6.87 | 0.32% |
| S&P 500 | 1,110.63 | 4.98 | 0.45% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 53.00 01:02 PM EST | |
|---|---|---|
| Day High | 53.76 09:30 AM EST |
|
| Range | 0.76 |
| Volume | 3.39 M | |
|---|---|---|
| 30-Day Avg Vol | 4.65 M |
|
| Difference | -27.12% |
| Market Cap | 48.48 B | |
|---|---|---|
| Mkt Cap Chg | -100.32 M |
| Shares Out | 912.00 M | |
|---|---|---|
| % Shrs Traded | 0.37% | |
| 1yr EPS Est | 4.187 |
| 52-Wk Low | 40.50 | |
|---|---|---|
| 52-Wk High | 54.95 |
|
| Range | 14.45 |
| Prev Close | 53.27 11/24/09 | |
|---|---|---|
| Today's Open | 53.75 | |
| Change | 0.90% |
| Dividend (TTM) | 0.58076 | |
|---|---|---|
| Div Yield (TTM) | 1.10% | |
| Ex-Div Date | 11/06/2009 | |
| Div Date | 12/04/2009 |
|
| Short Interest | 10 M |
| Revenue (LFY) | 11.08 B | |
|---|---|---|
| Earnings (LFY) | 635.00 M | |
| Earnings (MRQ) | 674.72 M | |
| Next Earn Est | 0.934 | |
| Next Earnings | 02/15/2010 |
|
| EPS (TTM) | 1.1302 | |
| 1yr EPS Growth | 31.25% |
| P/E Ratio (TTM) | 54.24 | |
|---|---|---|
| P/E Ratio (Fwd) | 12.00 | |
| PEG Ratio | 0.75 | |
| Return on Equity | 4.38 | |
| Beta | 0.20 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of hundreds of brand-name ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.934 2/15/10 | — — |
—
—
|
| Last Quarter | 0.879 9/30/09 | 0.89 9/30/09 |
0.011
Beat
|
| 2 Quarters Ago | 0.804 6/30/09 | 0.83 6/30/09 |
0.026
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.69 B | 11.08 B |
| Gross Profit | 2.00 B | 5.97 B |
| Operating Income | 883.69 M | 2.67 B |
| Net Income | 674.72 M | 635.00 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts